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1. PURPOSE 
The purpose of this calculation is to provide a bounding dose consequence analysis of the 
immobolized plutonium (can-in-canister) waste form to be handled at the Monitored Geologic 
Repository (MGR) at Yucca Mountain. The current concept for the Plutonium Can-in-Canister 
waste form is provided in Attachment III. A typical design basis event (DBE) defines a scenario 
that generally includes an initiating event and the sequences of events that follow. This analysis 
will provide (1) radiological releases and dose consequences for a postulated, bounding DBE and 
(2) design-related assumptions on which the calculated dose consequences are based. This 
analysis is part of the safety design basis for the repository. Results will be used in other 
analyses to determine or modify the safety classification and quality assurance level of repository 
structures, systems, and components (SSCs). 
The Quality Assurance (QA) program applies to this calculation. The work reported in this 
document is part of the analysis of MGR DBEs and is performed using AP-3.12Q, Calculations. 
The work done for this analysis was evaluated according to QAP-2-0, Control of Activities. This 
evaluation determined that such activities are subject to DOE/RW/0333P, Quality Assurance 
Requirements and Description (DOE 1998), requirements. This calculation is quality affecting 
because the results may be used to support analyses of repository SSCs per QAP-2-3, 
Classification of Permanent Items. 
2. METHOD 
The calculations described in this document are made with equations solved in Excel 97 
spreadsheets. Performing the calculations in spreadsheets offers several advantages: (1) dose 
estimates are easily understood since calculations are easily checked, (2) the calculations for 
release, transport, mitigation, and dispersion are easily combined into one electronic document, 
and (3) dose sensitivity studies can be easily performed. 
The equations described in this section are used to calculate: 
• Source Terms 
• Inhalation and Air Submersion Dose Calculations, and 
• Committed Dose Equivalent (CDE), Deep Dose Equivalent (DDE), Committed Effective 
Dose Equivalent (CEDE), and Total Effective Dose Equivalent (TEDE) Calculations. 
2.1 SOURCE TERMS 
The source term released to the environment by a postulated DBE from the Pu waste in a Pu can-
in-canister canister is calculated using equation (1) (DOE 1994, p. 1-2). 
STjj* = MAR,.* x DRhPu x ARFJtPu x RFJtPu x LPFJiPu (1) 
where, 
STjPu - the amount of the j * isotope in the Pu waste that is released to the environment 
per canister [Ci/canister] 
MARjPu - the "material-at-risk" of the j t h isotope in the Pu waste per canister [Ci/canister] 
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DRjPu - the fraction of the j t h isotope in the "material-at-risk" that is affected by the DBE 
(i.e., the damage ratio) [unitless] 
ARFjPu - the airborne release fraction of the j * isotope applicable to the DBE [unitless] 
RFjPu - the respirable fraction of the j t h isotope applicable to the DBE [unitless] 
LPFJPu - the leak path factor of the j t h isotope applicable to the DBE [unitless]. 
2.2 INHALATION AND SUBMERSION DOSE CALCULATIONS 
The inhalation dose to an individual from each isotope in the source term from the Pu waste per 
Pu can-in-canister canister is calculated using equation (2) per Regulatory Guide 1.109. 
tinh _ P T -, %_^ DDw „„ ,„ , , w n/^Z7'»A 
Q 
DJIPU =ST.Puxj-xBRx conv x DCFJf (2) 
While the air submersion dose is calculated using equation (3). Note that source term, ST, has 
been modified by dividing out the respirable fraction, RF, in equation (3) since the air 
submersion dose should not be modified by the fraction of the source material that is respirable. 
DiU=T^ x Ix cmv x DCFjt & RF,Pu Q 
where, 
D'j!k,ptt " radiation dose from the j t h isotope of the Pu waste to the kth "organ" due to 
inhalation [rem] 
Dj"*Pu - radiation dose from the j t h isotope of the Pu waste to the kth "organ" due to 
air submersion [rem] 
k - "organ" index, where "organs" are gonads, breast, lungs, red marrow, bone 
surface, thyroid, remainder, effective, and skin [unitless] 
Q 
BR - breathing rate [m3/s] 
■"""A +1-1= ;~v>„i„+;~*, JA»<> ~™-.T,=,-r,;«», +v,~+™. ^e +v.a ;* ^ ^ + = « = +%,. +u„ uth 
- atmospheric dispersion factor [s/m3] 
DCFj"k - the inhalation dose conversion factor of the j isotope for the k organ 
[Sv/Bq] 
DCFjf - the submersion dose conversion factor of the j t h isotope for the kth organ 
[(Sv m3)/(Bq s)] 
conv - DCF unit conversion factor: 3.7 x 1012 (rem Bq)/(Ci Sv) = 3.7 x 1010 
(Bq)/(Ci) x 100 (rem/Sv) (Eckerman et al. 1988, p. 121). 
The total inhalation dose to an individual from each isotope in the Pu and HLW source terms in 
the Pu can-in-canister is calculated by equation (4). 
Dj!l=DJlPu+(l-x)D%MLW (4) 
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While the air submersion dose is calculated using equation (5). 
where, 
D^=D-lPu+(l-x)D-lHLW (5) 
DfhkMLW - radiation dose from the j * isotope of the HLW to the k* "organ" due to 
inhalation [rem] 
DJbkHLW - radiation dose from the j * isotope of the HLW to the k* "organ" due to air 
submersion [rem] 
x - the fraction of the Pu can-in-canister canister that is Pu waste [unitless] 
DJj - radiation dose from the j f l l isotope of all the waste in a Pu can-in-canister 
canister to the k* "organ" due to inhalation [rem] 
Dj"k - radiation dose from the j * isotope of all the waste in a Pu can-in-canister 
canister to the k* "organ" due to air submersion [rem]. 
The HLW doses per HLW canister are obtained from the High-Level Vitrified Waste Dose 
Calculation (CRWMS M&O 1999, Attachment VII-1). 
2.3 CDE, DDE, CEDE, AND TEDE CALCULATIONS 
The Committed Dose Equivalent (CDE), the Deep Dose Equivalent (DDE), the Committed 
Effective Dose Equivalent (CEDE), the Total Effective Dose Equivalent (TEDE), and the dose 
equivalent to the lens of the eye, the skin and extremities are calculated. The equations used to 
produce these dose equivalents in terms of the radiation doses calculated in Section 5.3 are 
shown here. 
The TEDE and the CDE + DDE dose measures, ignoring the ingestion dose pathway 
[Assumption 3.5], are expressed as: 
TEDE = CEDE + DDE = ^ D ^ , + Y.Kff^e (6) 
j j 
CDEk + DDE = J ] Dfk + J ] Dsfbeffective where k * effective or skin (7) 
j j 
where, 
TEDE - total effective dose equivalent [rem] 
CEDE - committed effective dose equivalent [rem] 
DDE - deep dose equivalent [rem] 
CDEk - committed dose equivalent to the k* organ [rem]. 
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The skin and extremities dose is expressed as: 
SKIN^IXi, (8) 
j 
where, 
SKIN - dose to the skin & extremities [rem]. 
3. ASSUMPTIONS 
3.1 A restricted area boundary of 5,000 meters will be established around the Waste Handling 
Building (WHB). This assumption is the basis for selection of a 5,000-meter distance for 
estimating atmospheric dispersion factors. Basis: This value is based on the restricted area 
boundary established in the MGR Requirements Document (YMP 1999, Section 3.3.J). 
Usage: This assumption is used in the off-site dose calculations in Sections 3.3, 5.1, 5.2.3 
and 5.2.4. 
3.2 It is assumed that during non-mechanistic breach of the Plutonium Can-in-Canister 
canister, the release of radionuclides occurs within a 2-hour period. Basis: This is a 
conservative assumption for the non-mechanistic release. This approach is consistent with 
Section C.i of Regulatory Guide 1.25, Assumptions Used for Evaluating Potential 
Radiological Consequences of a Fuel Handling Accident in the Fuel Handling and Storage 
Facility for Boiling and Pressurized Water Reactors. Usage: This assumption is used in 
the off-site dose calculations in Section 5.3. 
3.3 An adult breathing rate of 3.33 x 10"4 m3/s (20 liters/min) was assumed for all dose 
calculations. Basis: This is based on the Reference Man breathing rate established in ICRP 
23 (ICRP 1974, p. 346). This breathing rate is based on the volume intake of air for "light 
activity" and is considered to be appropriate for DBE accident scenarios resulting in short-
term (< 8-hour) exposures to the public at the 5,000-meter site boundary [Assumption 3.1]. 
The scientific community generally accepts this assumption and has found it to be 
technically defensible. Usage: This assumption is used in the off-site dose calculations in 
Sections 5.2.4 and 5.3 and Attachment II-6, II-7, II-9,11-11,11-13,11-15 and 11-17. 
3.4 The atmospheric dispersion factors (x/Q) are taken from an Inter-Office Correspondence 
from Walt S chalk and Doug Landwehr to Kelvin Montague, "Preliminary x/Q 
Concentration Estimates Using Nuclear Regulatory Commission (NRC) Regulatory Guide 
1.145 as Implemented by the XQ145 Software Routine" (Schalk, W. and Landwehr, D. 
1998, Table 3). Basis: The values were calculated using the methodology outlined in 
Regulatory Guide 1.145. The maximum values that were exceeded 0.5% of the time were 
used for dispersion calculations in this report, and are assumed applicable to mechanistic 
and non-mechanistic events. Usage: This assumption is used in the off-site dose 
calculations in Section 5.2.3. 
3.5 Only inhalation and air submersion doses are considered in this calculation; the potential 
doses from ingestion, water immersion, and contaminated soil are ignored. Basis: This 
assumption implies that these doses are negligible in comparison to the combined 
inhalation and air submersion dose and/or the receptors at the assumed site boundary are 
evacuated shortly after the postulated event, thus precluding these source term pathways. 
Usage: This assumption is used in the off-site dose calculations in Sections 2.3 and 5.3.3. 
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3.6 For isotopes with multiple clearance classes, the lung clearance class that yields the highest 
inhalation DCF is assumed on a per organ basis. Basis: This assumption maximizes the 
calculated inhalation doses. The DCFs generated by the Environmental Protection Agency 
are generally accepted by the scientific community and found to be technically defensible. 
Thus, selecting the largest DCF value on a per organ basis is conservative. Usage: This 
assumption is used in the off-site dose calculations in Section 5.2.5. 
3.7 It is assumed that the airborne release fraction (ARF) for plutonium in a can-in-canister 
canister is equal to 1.6 x 10"3. This fraction will be applied to the release of all the 
radionuclides from Pu waste in a DBE that may potentially cause a canister to breach. 
Basis: This assumption is based on brittle fracture studies made on SYNROC, a ceramic 
material similar to the plutonium ceramic waste form. These studies were performed at 
Argonne National Laboratory and are reported in ANL (1982) Table 6, page 24. The values 
are considered conservative because the impact tests on SYNROC were preformed at much 
higher impact energies than anticipated during a drop of the plutonium can-in-canister at 
the MGR. Usage: This assumption is used in the off-site dose calculations in Sections 
5.2.1, 5.3.1 and 6 and Attachment II-7, II-9,11-11,11-13,11-15 and 11-17. 
3.8 A respirable fraction (RF) of 1.0 is used in this calculation. This fraction will be applied to 
the release of all the radionuclides from Pu waste in a DBE that may potentially cause a 
canister to breach. Basis: This assumption is conservatively based on worst case. Usage: 
This assumption is used in the off-site dose calculations in Section 6 and Attachment II-6, 
II-7, II-9,11-11,11-13,11-15 and 11-17. 
3.9 A leak path factor (LPF) of 1.0 is used in this calculation. Basis: Using a LPF of 1.0 
implies taking no credit for source term reduction mechanisms such as gravitational settling 
or operation of the WHB ventilation system (i.e., HEPA filtration of the source term before 
it is released to the environment). This is a bounding assumption and hence, technically 
defensible. Usage: This assumption is used in the off-site dose calculations in Section 5.3.1 
and Attachment II-7, II-11 and 11-15. 
3.10 A damage ratio (DR) of 1.0 is used in this calculation. Basis: Using a DR of 1.0 implies 
taking no credit for structural integrity provided by the can, tube, and canister the Pu is 
contained within. In addition, if the Pu can-in-canister canister is contained within a 
shipping cask or a disposal container, no credit is taken for the structural integrity of these 
systems as well. This is a bounding assumption and hence, technically defensible. Usage: 
This assumption is used in the off-site dose calculations in Section 5.3.1 and Attachment II-
7,11-11 and 11-15. 
3.11 In calculating the fraction of inventory at risk, the only significant radioactive isotopes in 
the Pu canisters are listed in Table 5-1. Basis: This data is based on the Report on Intact 
and Degraded Criticality for Selected Plutonium Waste Forms in a Geologic Repository, 
Volume II: Immobilized in Ceramic (CRWMS M&O 1998, Table 2.2.3-4). Usage: This 
assumption is used in the off-site dose calculations in Section 5.2.1 and Attachment II-2. 
3.12 In calculating the fraction of inventory at risk, it is assumed that all of the canisters 
containing Pu waste have radioisotopes with activities approximately equal to the values 
listed in Table 5-1. Basis: This data is based on the Report on Intact and Degraded 
Criticality for Selected Plutonium Waste Forms in a Geologic Repository, Volume II: 
Immobilized in Ceramic (CRWMS M&O 1998, Table 2.2.3-4). If the values in Table 5-1 
may potentially not be bounding then an uncertainty analysis must be performed to 
determine the effect of activity on the doses relative to the dose limits. Usage: This 
assumption is used in the off-site dose calculations in Section 5.2.1 and Attachment II-2. 
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3.13 The inhalation dose per high level waste (HLW) canister for the HLW waste form is based 
on a maximum drop height of 448 inches. Basis: This data is based on the High Level 
Vitrified Waste Dose Calculation (CRWMS M&O 1999, Attachment VII-1). Usage: This 
assumption is used in the off-site dose calculations in Sections 5.1, 5.2.6 and 5.3.1 and 
Attachment II-2. 
4. COMPUTER SOFTWARE AND MODEL USAGE 
4.1 SCIENTIFIC AND ENGINEERING SOFTWARE 
Not Applicable. 
4.2 COMPUTATIONAL SUPPORT SOFTWARE 
Excel 97 for Windows 
All dose calculations performed to support this analysis were generated with Excel 97 
spreadsheets, and run on Pentium personal computers. The Excel 97 platform was used to 
calculate doses for DBE scenarios analyzed (see Attachment II). The process, which was used to 
calculate doses, is described in Section 5.3. Dose results presented in this calculation were 
generated by the Excel spreadsheet and verified by visual inspection. 
5. CALCULATIONS 
5.1 CALCULATION DESCRIPTION 
The purpose of this radiological analysis is to estimate the radioactive releases and resultant 
doses per canister to the public from a DBE that is assumed to occur within the WHB. In this 
calculation, doses received are by an off-site individual at 5-km from the radionuclide release 
point [Assumption 3.1]. Doses to individual organs and to the whole body are calculated, 
respectively, for exposure via inhalation and submersion. 
The calculations, as described in the Methods Section (Section 2), are performed only for the 
plutonium can-in-canister waste form and are located in Attachment II. No calculations for the 
HLW are performed in this calculation, see High Level Vitrified Waste Dose Calculation 
(CRWMS M&O 1999) for details on the doses produced by this waste form [Assumption 3.13]. 
5.2 INPUT DATA 
Design inputs are for preliminary design. These design inputs will require subsequent 
qualification before the analysis can be used to support procurement, fabrication, or construction 
activities. 
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5.2.1 Source Terms - Radionuclide Inventories 
According to the Report on Intact and Degraded Criticality for Selected Plutonium Waste Forms 
in a Geologic Repository, Volume II: Immobilized in Ceramic (CRWMS M&O 1998, Table 
2.2.3-4), the activity for radionuclides contained in a Pu can-in-canister canister, with the units 
curies per kilogram of plutonium plus americium (americium is included in this total due to the 
relatively rapid decay of 241Pu to 2 Am) in the feed in the year 2010, are equal to values in Table 
5-1 [Assumption 3.11]. This table lists the activity for the case where only 18-metric tons of 
plutonium, which contains impurities making it unsuitable for MOX reactor fuel, is disposed and 
the case where all 50-metric tons of surplus plutonium are disposed. Note that the plutonium 
containing the impurities (the 18-metric ton case) has the limiting activity per kilogram of 
plutonium plus americium in the feed (see Attachment II) [Assumption 3.12]. In addition, note 
that each of the radionuclides listed in Table 5-1 is considered to be released in particulate form 
rather than as a gas or a volatile. Thus, a single airborne release fraction (ARF) may be used to 
represent the release of these particulate due to a potential DBE [Assumption 3.7]. 
Table 5-1. Curies per kg of Total Plutonium plus Americium 
Isotope 
238P u 
239P u 
240P u 
241 P u 
241Am 
242P u 
Activity (Ci per kg of Pu + Am) 
18-Metric Ton Case 
4.2 
56.3 
19.2 
165.0 
25.0 
0.0034 
50-Metric Ton Case 
2.1 
57.7 
15.0 
99.3 
15.1 
0.00161 
5.2.2 Plutonium Mass 
The mass of the plutonium within the Pu can-in-canister canister is obtained from the Report on 
Intact and Degraded Criticality for Selected Plutonium Waste Forms in a Geologic Repository, 
Volume II: Immobilized in Ceramic (CRWMS M&O 1998, pp. 2 and 11). Table 5-2 presents the 
data for the plutonium waste form. Essentially in each Pu can-in-canister canister there are 7 
tubes, 28 cans, and 560 disks of surplus Pu. 
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Table 5-2. Plutonium Waste Form Mass Data 
Property 
Disks per can 
Cans per tube 
Tubes per Pu can-in-canister canister 
Ceramic mass per can 
Maximum Pu per can-in-canister canister 
Maximum fraction of HLW displaced by Pu 
in a canister 
Value 
20 
4 
7 
9.755 kg 
28.68 kg 
0.12 
5.2.3 Atmospheric Dispersion Factors (x/Q) 
The atmospheric dispersion factors are based on Yucca Mountain site-specific data obtained 
from the Environmental Field Program (Schalk, W. and Landwehr, D. 1998, Table 3). The values 
were calculated using the equations prescribed in Regulatory Guide 1.145. An atmospheric 
dispersion factor of 4.68 x 10"5 sec/m3 [Assumption 3.4] is used in the dose calculations for the 
assumed 5-km dose receptor [Assumption 3.1]. 
5.2.4 Breathing Rate 
An adult breathing rate of 3.33 x 10"4 m3/s (20-litres/min) was assumed for all dose calculations 
[Assumption 3.3]. This is based on the Reference Man breathing rate established in ICRP 23 
(ICRP 1974, p. 346) and accepted by the NRC for accident analysis (NRC 1997, p. 7-7). This 
breathing rate is based on the volume intake of air for "light activity" and is considered to be 
appropriate for DBE accident scenarios resulting in short-term (< 8-hour) exposures to the public 
at the 5,000-meter site boundary [Assumption 3.1]. 
5.2.5 Inhalation and Submersion Dose Conversion Factors (DCFs) 
Inhalation and air submersion DCFs are taken from Federal Guidance Report 11 and Federal 
Guidance Report 12, respectively (Eckerman et al. 1988 and Eckerman et al. 1993). A listing of 
the DCFs used in this analysis is given in Attachment II. DCFs generated by the EPA are 
generally accepted by the scientific and engineering community and found to be technically 
defensible. 
The inhalation DCF of an isotope is dependent in part on its chemical form. This dependence is 
accounted for by the lung clearance class (D - daily, W - Weekly, Y - Yearly) used to evaluate 
the DCF of a given isotope. Some isotopes have only one lung clearance class, others have 
multiple lung clearance classes. For isotopes with multiple lung clearance classes, the lung 
clearance class that yields the highest DCF is assumed on a per organ basis [Assumption 3.6]. 
For example, Pu-238 (which has W- and Y-clearance classes) has the highest lung inhalation 
DCF for the Y-clearance class, while all of the other organs have the highest inhalation DCF for 
the W-clearance class. 
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5.2.6 HLW Doses Per HLW Canister for the HLW Waste Form 
The HLW doses per HLW canister for the HLW waste form are obtained from the High-Level 
Vitrified Waste Dose Calculation for SRS HLW (CRWMS M&O 1999, Attachment VIM). 
Table 5-3 presents the data for the inhalation and submersion dose for each organ [Assumption 
3.13]. 
Table 5-3. HLW Doses per HLW Canister 
Organ 
Gonad 
Breast 
Lung 
R Marrow 
B Surface 
Thyroid 
Remainder 
Effective 
Skin 
Lens of Eye 
Dose (rem) 
Inhalation 
1.57x10-1 
1.52x10-3 
2.11 x100 
8.94x10-1 
1.06x10+1 
1.52x10-3 
3.92x10-1 
6.42x10-1 
N/A 
N/A 
Submersion 
1.15x10-5 
1.31 x10-5 
1.14x10-5 
1.11 X10-5 
1.89x10-5 
1.18x10-5 
1.09x10-5 
1.18x10-5 
5.14x10-5 
0.0 
5.2.7 HEPA Filter Mitigation Factor 
A single-stage HEPA filter has, by definition, an efficiency of no less than 99.97% (Burchsted et 
al. 1978, p. 9). Hence a mitigation factor of 3.0 x 10"4 can be applied to all particulate 
radionuclide releases that are drawn through the exhaust HEPA filters by the WHB heating, 
ventilation, and air-conditioning (HVAC) system. 
5.3 CONSEQUENCE ANALYSIS 
The purpose of this radiological analysis is to estimate the radioactive releases and resultant 
doses to the public from a bounding DBE that is assumed to occur within the WHB [see 
Assumption 3.2]. In this analysis, the doses received by an off-site individual at 5-km from the 
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radionuclide release point are calculated. Doses to individual organs and to the whole body are 
calculated for exposure through inhalation and submersion. 
First, an unmitigated analysis is performed and if it successfully demonstrates compliance with 
the regulatory requirements, using this approach could result in a simple licensing approach for 
DBEs with a minimum need for safety-related SSCs. A mitigated analysis is also performed to 
estimate the expected dose magnitude result from the DBE using credit for physical mechanisms 
that could mitigate the release in the event unmitigated consequences do not meet regulatory 
requirements. 
The dose produced by both the Pu waste and the HLW contained in a Pu can-in-canister canister 
must be considered in this dose assessment for the bounding DBE. According to the Report on 
Intact and Degraded Criticality for Selected Plutonium Waste Forms in a Geologic Repository, 
Volume II: Immobilized in Ceramic (CRWMS M&O 1998, p. 11), the plutonium bearing 
canisters contain 88% of their maximum capacity for HLW glass (i.e., Pu makes up 12% of these 
canisters). Thus, considering HLW is homogeneously distributed through a HLW canister, the 
dose associated with the HLW in a canister containing Pu is the dose from a canister containing 
only HLW reduced by 12%. This is done for the dose associated with each organ prior to any 
additions to doses associated with the Pu. 
5.3.1 Source Terms 
This section presents the radionuclide source terms that are potentially available for release 
during a bounding DBE. The inhalation source terms are formed by the radionuclides available 
for release if the engineered barriers (i.e., the canisters) are breached. A person engulfed by the 
released radioactive plume, who inhales the radionuclides suspended in the plume, receives the 
inhalation dose. The inhalation doses are the 50-year committed dose equivalents. No crud is 
associated with these canisters since they are poured forms whose surfaces are neither corrosive 
nor exposed to a corrosive environment such as water. 
Source terms are generated in units of curies so that they may be easily converted to units of 
dose. Each of the isotopes in the source terms is evaluated for its dose contribution to the gonad, 
breast, lung, red marrow, bone surface, thyroid, remainder, and whole body. Attachment II 
details these source term calculations for the Pu in the Pu can-in-canister canister. Details of the 
source term calculation for HLW can be found in the High Level Vitrified Waste Dose 
Calculation (CRWMS M&O 1999) [Assumption 3.13]. The HLW dose results from this 
calculation will be combined with the dose calculations for the Pu waste established in this 
analysis (as shown in Section 5.3.2) to determine the total potential dose produced by a breached 
canister containing Pu in cans and HLW. 
The source term released to the environment by a postulated DBE for the Pu waste in a Pu can-
in-canister canister is calculated by Equation (1) in Section 2: 
STLPu = MAR.Pu xDR lPu x ARFhPu xRFhPu xLPF.Pu (1) 
Note that for Pu waste in a Pu can-in-canister canister, the damage ratio (DR), the leak path 
factor (LPF), and the airborne release fraction times the respirable fraction (ARF x RF) are 
constants. DR and LPF are assumed equal to one [Assumptions 3.10 and 3.9] for each isotope. 
ARF x RF is assumed equal to 1.6 x 10 for each isotope in this analysis [Assumption 3.7]. 
CAL-WPS-SE-000001, REV 00 13 September 1999 
5.3.2 Inhalation and Submersion Dose Calculations 
The inhalation dose to an individual from each isotope in the source term from the Pu waste per 
Pu can-in-canister canister is calculated by Equation (2) in Section 2: 
Z>fi,P» = STLPu x^xBRxconvxDCF% (2) 
while the air submersion dose is calculated by Equation (3): 
STj 
j,Pu 
 v 
D7bkPu = ~J^L x - * conv x DCFjf (3) >'k'Pu RF.lPu Q 
The total inhalation dose to an individual from each isotope in the source term in the Pu can-in-
canister is calculated by Equation (4): 
Djl=D;lPu+(l-x)D%MLIV (4) 
while the air submersion dose is calculated by Equation (5): 
D^=D^Pu+(l-x)D-lHLW (5) 
The radiation doses from the HLW are calculated in the High Level Vitrified Waste Dose 
Calculation (CRWMS M&O 1999). The maximum fraction of the Pu can-in-canister canister 
that is Pu waste is found in Table 5-2. Note that the radiation dose from the Pu waste in the 
above equations is on a per canister basis, which assumes some maximum fraction of a canister 
contains Pu waste. The values calculated for HLW are based on a canister filled entirely with 
HLW. 
5.3.3 CDE, DDE, CEDE, and TEDE Calculations 
In this section, the equations used to produce dose equivalents in terms of the radiation doses 
calculated in the Section 5.3.2 and Attachment II are shown. 
The TEDE and the CDE + DDE dose measures, ignoring the ingestion dose pathway 
[Assumption 3.5], are expressed as Equations (6) and (7): 
TEDE = CEDE + DDE = J]DJ^ctive + ^D^ctive (6) 
j j 
CDEk +DDE = J] *>% + Z Dmec„e where k * effective or skin (7) 
j 
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The skin and extremities dose is equal to calculated using Equation (8): 
SKIN^2X*,„ (8) 
5.4 DBE DOSE CONSEQUENCES 
Equations (1) through (8) are used to establish the dose consequences per canister. In the 
unmitigated calculation, the canisters, shipping casks, and disposal containers are assumed to 
provide no mitigation for potential releases. In addition, no credit is taken for any hindrance the 
WHB and other structures may provide against the leakage of the released radionuclides to the 
site boundary. This includes not taking credit for any HEPA filters that may be present in these 
facilities. 
6. RESULTS 
The offsite dose consequence results from the calculations in Attachment II for the bounding 18-
metric ton case are summarized in Table 6-1. Table 6-1 summarizes the unmitigated doses and 
the mitigated dose consequences, which were produced assuming the presence of HEPA filters 
with an efficiency of 3.0 x 10"4. No other credit has been taken for other potential mitigation 
features (e.g., the shipping cask). 
It should be noted that the maximum fraction of Pu waste in the Pu can-in-canister canister is an 
input to this analysis as opposed to the maximum fraction of HLW in this canister due to the 
significant impact the smaller quantity of Pu waste has on the doses. This input essentially limits 
the amount of Pu allowed in these canisters. Table 6-1 summarizes the sensitivity of the results 
to the amount of plutonium in these can-in-canister canisters. In addition, Figure 6-1 illustrates 
how the TEDE and the maximum organ dose (CDE+DDE) vary with the fraction of Pu waste in 
a canister. The values in this figure were obtained by varying the fraction of HLW displaced by 
Pu in a canister, which modifies the dose contribution of the HLW. In addition, the Pu dose 
contribution was corrected with the ratio of the HLW displacement fraction to 0.12 (the current 
displacement fraction). This latter correction is made to correct for the addition or reduction of 
Pu mass with the change in the displacement fraction (e.g., a displacement fraction of 0.1 reduces 
the amount Pu mass by 0.1/0.12 = 0.833 or 16.7%). Attachment V contains the calculations 
relevant to this Figure. Note, however, that the reference displacement fraction in this analysis is 
considered equal to 0.12. 
Another important factor in these dose calculations is the ARF. In this calculation, the ARF is 
equal to a constant [Assumption 3.7]. However, if the ARF fraction did vary for the Pu waste, 
say with a postulated drop height, then Figure 6-2 illustrates how the Pu and total canister TEDE 
and maximum organ dose (i.e., bone surface, CDE+DDE) vary with this fraction. The doses in 
this figure were calculated by simply multiplying the plutonium portion of the doses (for the 0.12 
unmitigated case in Table 6-1) by the ratio of the selected ARF divided by the 1.6 x 10"3 and 
adding the HLW doses. The HLW doses are not modified in this calculation by the ARF. 
Attachment V contains the calculations relevant to this Figure. 
Other inputs that may significantly impact the dose results (e.g., increase doses) in this 
calculation include: (1) the assumed location of the restricted area boundary (i.e., 5,000-m 
[Assumption 3.1]), (2) the x/Q value that was obtained from an unconfirmed MGR calculation 
[Assumption 3.4], (3) the breathing rate that was obtained from an unconfirmed source 
[Assumption 3.3], and (4) the activity of the radionuclides in the Pu waste [Assumption 3.12]. 
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Table 6-1. Mitigated and Unmitigated Dose Consequences 
for a Breached Pu Can-In-Canister Canister 
Fraction of HLW 
Displaced by Pu 
0.10 (Unmitigated) 
0.10 (Mitigated) 
0.12 (Unmitigated) 
0.12 (Mitigated) 
0.20 (Unmitigated) 
0.20 (Mitigated) 
Number 
of 
Canisters 
lPu 
lPu 
lPu 
lPu 
lPu 
lPu 
Dose (rem) 
TEDE 
28.3 
(27.7-rem due 
to Pu only) 
0.0085 
(0.0083-rem 
due to Pu only) 
33.8 
(33.3-remdue 
to Pu only) 
0.010 
(9.98-mrem due 
to Pu only) 
56.0 
(55.4 rem due 
to Pu only) 
0.017 
(0.0166 rem 
due to Pu only) 
Highest 
CDE + 
DDE 
513.3 
(bone 
surface) 
0.15 
(bone 
surface) 
613.9 
(bone 
surface) 
0.18 
(bone 
surface) 
1016.0 
(bone 
surface) 
0.305 
(bone 
surface) 
Skin 
4.6 xlO"5 
1.4 xlO"8 
4.6 x 10"5 
1.4 xlO"8 
4.2 xlO"5 
1.3 x 10"8 
Lens of 
the Eye 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
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7. ATTACHMENTS 
Attachment I Acronyms 
Attachment II Dose Consequence Analysis for Pu Can-in-Canister Canisters 
Attachment III Pu Can-In-Canister Sketch 
Attachment IV Document Input Reference Sheets 
Attachment V Calculations for Figures 6-1 and 6-2 
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Attachment I 
Acronyms 
ANL 
ARF 
BR 
CDA 
CDE 
CEDE 
DBE 
DCF 
DDE 
DR 
EPA 
HEPA 
HLW 
HVAC 
ICRP 
ISFSI 
LPF 
M&O 
MAR 
MGR 
NRC 
QA 
RF 
SSC 
ST 
TBD 
TBV 
TEDE 
WHB 
Argonne National Laboratory 
Airborne Release Fraction 
Breathing Rate 
Controlled Design Assumptions 
Committed Dose Equivalent 
Committed Effective Dose Equivalent 
Design Basis Event 
Dose Conversion Factor 
Deep Dose Equivalent 
Damage Ratio 
Environmental Protection Agency 
High-Efficiency Particulate Air 
High-Level Waste 
Heating, Ventilation and Air-Conditioning 
International Commission on Radiological Protection 
Independent Spent Fuel Storage Installation 
Leak Path Factor 
Management and Operating Contractor 
Material-at-Risk 
Monitored Geologic Repository 
Nuclear Regulatory Commission 
Quality Assurance 
Respirable Fraction 
Structure, System, and Component 
Source Term 
To Be Determined 
To Be Verified 
Total Effective Dose Equivalent 
Waste Handling Building 
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Attachment II 
Dose Consequence Analysis for Pu Can-in-Canister Canisters 
The following pages contain a listing of the Excel 97 spreadsheets used to calculate the dose for 
the Pu can-in-canister canister, which includes the HLW in this canister. The following is a 
listing of the spreadsheets involved (note that the equations in the text are not implemented in the 
same exact form in the spreadsheets): 
• Pu MAR - lists the material-at-risk in the Pu can-in-canister (Table 5-1) [No 
calculations]. 
• DCF - dose conversion factors (see Section 5.2.5) [No calculations]. 
• Pu Source Term (18 MT) - calculation of source terms for a Pu can-in-canister 
for the 18-MT case. The calculations performed in this sheet involve multiplying the 
material at risk (MAR) by the dose conversion factors (DCFs) and the conversion 
factors for sieverts to rem and curies to bequerels for each radio-isotope and each 
organ. These source terms are then added together for each organ. 
• Pu Source Term (50 MT) - calculation of source terms for a Pu can-in-canister 
for the 50-MT case. The calculations performed in this sheet involve multiplying the 
material at risk (MAR) by the dose conversion factors (DCFs) and the conversion 
factors for sieverts to rem and curies to bequerels for each radio-isotope and each 
organ. These source terms are then added together for each organ. 
• HLW Inputs - organ doses as calculated in High Level Vitrified Waste Dose 
Calculation (CRWMS M&O, 1999b) [No calculations]. 
• Pu Canister Dose no HEPAs (0.1) - calculation of unmitigated doses for a 
Pu/HLW canister with 10% of the HLW displaced by Pu waste. The Pu waste form 
doses are calculated in this sheet by multiplying the source terms for each organ, as 
calculated in the Pu Source Term (18 MT) sheet, by the ARF, RF (if applicable), 
Mitigation Factor, Breathing Rate, and X/Q value. These doses are then added to the 
doses from the HLW waste form which have been reduced by the fraction of HLW 
displaced by the Pu waste form. The following sheets all perform the same 
calculations with different mitigation factors and fractions of displaced HLW. 
• Pu Canister Dose W HEPAs (0.1) - calculation of mitigated doses for a Pu/HLW 
canister with 10% of the HLW displaced by Pu waste 
• Pu Canister Dose no HEPAs (0.12) - calculation of unmitigated doses for a 
Pu/HLW canister with 12% of the HLW displaced by Pu waste 
• Pu Canister Dose W HEPAs (0.12) - calculation of mitigated doses for a 
Pu/HLW canister with 12% of the HLW displaced by Pu waste 
• Pu Canister Dose no HEPAs (0.2) - calculation of unmitigated doses for a 
Pu/HLW canister with 20% of the HLW displaced by Pu waste 
• Pu Canister Dose W HEPAs (0.2) - calculation of mitigated doses for a Pu/HLW 
canister with 20% of the HLW displaced by Pu waste 
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MATERIAL AT RISK 
Isotope 
238Pu 
239Pu 
240Pu 
241Pu 
241Am 
242Pu 
Activity (Ci per kg of Pu + Am) 
50-Metric Ton Case 
2.1 
57.7 
15 
99.3 
15.1 
0.00161 
18-Metric Ton Case 
4.2 
56.3 
19.2 
165 
25 
0.0034 
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Exposure-to-Dose Conversion Factors for Inhalation 
Isotope 
238Pu 
239Pu 
240pu 
241Pu 
241Am 
242p u 
Committed Dose Equivalent per Unit Intake (Sv/Bq) 
Gonad 
2.80E-05 
3.18E-05 
3.18E-05 
6.82E-07 
3.25E-05 
3.02E-05 
Breast 
1.00E-09 
9.22E-10 
9.51E-10 
3.06E-11 
2.67E-09 
9.45E-10 
Lung 
3.20E-04 
3.23E-04 
3.23E-04 
3.18E-06 
1.84E-05 
3.07E-06 
R Marrow 
1.52E-04 
1.69E-04 
1.69E-04 
3.36E-06 
1.74E-04 
1.61E-04 
B Surface 
1.90E-03 
2.11E-03 
2.11E-03 
4.20E-05 
2.17E-03 
2.01E-03 
Thyroid 
9.62E-10 
9.03E-10 
9.05E-10 
1.24E-11 
1.06E-09 
8.79E-10 
Remainde 
7.02E-05 
7.56E-05 
7.56E-05 
1.31E-06 
7.82E-05 
7.18E-05 
Effective 
1.06E-04 
1.16E-04 
1.16E-04 
2.23E-06 
1.20E-04 
1.11E-04 
Exposure-to-Dose Conversion Factors for Submersion 
Isotope 
238pu 
239Pu 
240p u 
24,Pu 
241Am 
242Pu 
Committed Dose Equivalent per Unit Intake (Sv/s per Bq/m3) 
Gonad 
6.56E-18 
4.84E-18 
6.36E-18 
7.19E-20 
8.58E-16 
5.34E-18 
Breast 
1.27E-17 
7.55E-18 
1.23E-17 
8.67E-20 
1.07E-15 
1.03E-17 
Lung 
1.06E-18 
2.65E-18 
1.09E-18 
6.48E-20 
6.74E-16 
9.69E-19 
R Marrow 
1.68E-18 
2.67E-18 
1.65E-18 
5.63E-20 
5.21E-16 
1.43E-18 
B Surface 
9.30E-18 
9.47E-18 
9.26E-18 
2.19E-19 
2.87E-15 
7.90E-18 
Thyroid 
4.01E-18 
3.88E-18 
3.92E-18 
6.98E-20 
7.83E-16 
3.32E-18 
Remainde 
1.99E-18 
2.86E-18 
1.96E-18 
6.09E-20 
6.34E-16 
1.68E-18 
Effective 
4.88E-18 
4.24E-18 
4.75E-18 
7.25E-20 
8.18E-16 
4.01E-18 
Skin 
4.09E-17 
1.86E-17 
3.92E-17 
1.17E-19 
1.28E-15 
3.27E-17 
Lens of Eye 
0.00E+00 
0.00E+00 
0.00E+00 
0.00E+00 
0.00E+00 
0.00E+00 
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Plutonium Inhalation Source Term - 1 8 Metric Ton Case (28.68-kg Pu) 
Isotope 
23SPu 
239Pu 
2 4 0 p u 
24 ,Pu 
241Am 
242Pu 
Total 
Rem/Canister 
Gonad 
1.25E+10 
1.90E+11 
6.48E+10 
1.19E+10 
8.62E+10 
1.09E+07 
3.65E+11 
Breast 
4.46E+05 
5.51E+06 
1.94E+06 
5.36E+05 
7.08E+06 
3.41E+02 
1.55E+07 
Lung 
1.43E+11 
1.93E+12 
6.58E+11 
5.57E+10 
4.88E+10 
1.11E+06 
2.83E+12 
R Marrow 
6.77E+10 
1.01E+12 
3.44E+11 
5.88E+10 
4.62E+11 
5.81E+07 
1.94E+12 
B Surface 
8.47E+11 
1.26E+13 
4.30E+12 
7.35E+11 
5.76E+12 
7.25E+08 
2.42E+13 
Thyroid 
4.29E+05 
5.39E+06 
1.84E+06 
2.17E+05 
2.81E+06 
3.17E+02 
1.07E+07 
Remainder 
3.13E+10 
4.52E+11 
1.54E+11 
2.29E+10 
2.07E+11 
2.59E+07 
8.67E+11 
Effective 
4.72E+10 
6.93E+11 
2.36E+11 
3.90E+10 
3.18E+11 
4.00E+07 
1.33E+12 
Plutonium Submersion Source Term - 18 Metric Ton Case (28.68-kg Pu) 
Isotope 
2 3 S p u 
239Pu 
240Pu 
241Pu 
241Am 
242Pu 
Total 
(Rem-m3)/(s-Canister 
Gonad 
2.92E-03 
2.89E-02 
1.30E-02 
1.26E-03 
2.28E+00 
1.93E-06 
2.32E+00 
Breast 
5.66E-03 
4.51E-02 
2.51E-02 
1.52E-03 
2.84E+00 
3.72E-06 
2.92E+00 
Lung 
4.72E-04 
1.58E-02 
2.22E-03 
1.13E-03 
1.79E+00 
3.50E-07 
1.81E+00 
R Mar row 
7.49E-04 
1.60E-02 
3.36E-03 
9.86E-04 
1.38E+00 
5.16E-07 
1.40E+00 
B Surface 
4.14E-03 
5.66E-02 
1.89E-02 
3.83E-03 
7.61E+00 
2.85E-06 
7.70E+00 
Thyroid 
1.79E-03 
2.32E-02 
7.99E-03 
1.22E-03 
2.08E+00 
1.20E-06 
2.11E+00 
Remainder 
8.87E-04 
1.71E-02 
3.99E-03 
1.07E-03 
1.68E+00 
6.06E-07 
1.70E+00 
Effective 
2.17E-03 
2.53E-02 
9.68E-03 
1.27E-03 
2.17E+00 
1.45E-06 
2.21E+00 
Skin 
1.82E-02 
1.11E-01 
7.99E-02 
2.05E-03 
3.40E+00 
1.18E-05 
3.61E+00 
Lens Eye 
0.00E+00 
0.00E+00 
0.00E+00 
0.00E+00 
O.OOE+OO 
0.00E+00 
0.00E+00 
NOTES 
[A] Inhalation Source Term = [MAR (Ci/kg)] [28.68 kg/canister] [DCF(Sv/Bq)] [3.7 x 10 ,0Bq/Ci] [100 Rem/Sv] 
[B] Submersion Source Term = [MAR (Ci/kg)] [28.68 kg/canister] [DCF(Sv-m3/Bq-s)] [3.7 x 1010Bq/Ci] [100 Rem/Sv] 
[C] Maximum Plutonium per canister = 28.68 kg at 12% HLW volume displacement. 
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Plutonium Inhalation Source Term - 50 Metric Ton Case (28.68-kg Pu) 
Isotope 
2 3 8 p u 
239Pu 
240Pu 
241Pu 
241Am 
242Pu 
Total 
Rem/Canister 
Gonad 
6.24E+09 
1.95E+11 
5.06E+10 
7.19E+09 
5.21E+10 
5.16E+06 
3.11E+11 
Breast 
2.23E+05 
5.65E+06 
1.51E+06 
3.22E+05 
4.28E+06 
1.61E+02 
1.20E+07 
Lung 
7.13E+10 
1.98E+12 
5.14E+11 
3.35E+10 
2.95E+10 
5.24E+05 
2.63E+12 
R Marrow 
3.39E+10 
1.03E+12 
2.69E+11 
3.54E+10 
2.79E+11 
2.75E+07 
1.65E+12 
B Surface 
4.23E+11 
1.29E+13 
3.36E+12 
4.43E+11 
3.48E+12 
3.43E+08 
2.06E+13 
Thyroid 
2.14E+05 
5.53E+06 
1.44E+06 
1.31E+05 
1.70E+06 
1.50E+02 
9.01E+06 
Remainder 
1.56E+10 
4.63E+11 
1.20E+11 
1.38E+10 
1.25E+11 
I.23E+07 
7.38E+11 
Effective 
2.36E+10 
7.10E+11 
1.85E+11 
2.35E+10 
1.92E+11 
1.90E+07 
1.13E+12 
Plutonium Submersion Source Term - 50 Metric Ton Case (28.68-kg Pu) 
Isotope 
2 3 8 n 
Pu 
239Pu 
240Pu 
241Pu 
241 . 
Am 
242x, 
Pu 
Total 
(Rem-m3)/(s-Canister 
Gonad 
1.46E-03 
2.96E-02 
1.01E-02 
7.58E-04 
1.37E+00 
9.12E-07 
1.42E+00 
Breast 
2.83E-03 
4.62E-02 
1.96E-02 
9.14E-04 
1.71E+00 
1.76E-06 
1.78E+00 
Lung 
2.36E-04 
1.62E-02 
1.73E-03 
6.83E-04 
1.08E+00 
1.66E-07 
1.10E+00 
R Marrow 
3.74E-04 
1.63E-02 
2.63E-03 
5.93E-04 
8.35E-01 
2.44E-07 
8.55E-01 
B Surface 
2.07E-03 
5.80E-02 
1.47E-02 
2.31E-03 
4.60E+00 
1.35E-06 
4.68E+00 
Thyroid 
8.94E-04 
2.38E-02 
6.24E-03 
7.36E-04 
1.25E+00 
5.67E-07 
1.29E+00 
Remainder 
4.43E-04 
1.75E-02 
3.12E-03 
6.42E-04 
1.02E+00 
2.87E-07 
1.04E+00 
Effective 
1.09E-03 
2.60E-02 
7.56E-03 
7.64E-04 
1.31E+00 
6.85E-07 
1.35E+00 
Skin 
9.11E-03 
1.14E-01 
6.24E-02 
1.23E-03 
2.05E+00 
5.59E-06 
2.24E+00 
Lens Eye 
0.00E+00 
0.00E+00 
O.00E+OO 
0.00E+00 
0.00E+00 
0.00E+00 
O.OOE+00 
NOTES 
[A] Inhalation Source Term = [MAR (Ci/kg)] [28.68 kg/canister] [DCF(Sv/Bq)] [3.7 x 10I0Bq/Ci] [100 Rem/Sv] 
[B] Submersion Source Term = [MAR (Ci/kg)] [28.68 kg/canister] [DCF(Sv-m3/Bq-s)] [3.7 x 1010Bq/Ci] [100 Rem/Sv] 
[C] Maximum Plutonium per canister = 28.68 kg at 12% HLW volume displacement. 
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HLW Doses per HLW Canister 
Organ 
(1) 
Gonad 
Breast 
Lung 
R Marrow 
B Surface 
Thyroid 
Remainder 
Effective 
Skin 
Lens of Eye 
Inhalation Dose 
(rem) 
(11) 
1.57E-01 
1.52E-03 
2.11E+00 
8.94E-01 
1.06E+01 
1.52E-03 
3.92E-01 
6.42E-01 
NA 
NA 
Submersion Dose 
(rem) 
(12) 
1.15E-05 
1.31E-05 
1.14E-05 
1.11E-05 
1.89E-05 
1.18E-05 
1.09E-05 
1.18E-05 
5.14E-05 
0.00E+00 
CAL-WPS-SE-000001 REV 00 II-6 
Breathing Rate: 3.33E-04 (13) 
X/Q: 4.68E-05 (14) 
Mitigation Factor: 1 (15) 
September 1999 
Off-Site Inhalation Dose without HEPA Filters (10% HLW Displaced by Pu) 
Organ 
(1) 
Gonad 
Breast 
Lung 
R Marrow 
B Surface 
Thyroid 
Remainder 
Effective 
Pu-Dose 
(rem/can) 
(2) 
3.65E+11 
1.55E+07 
2.83E+12 
1.94E+12 
2.42E+13 
1.07E+07 
8.67E+11 
1.33E+12 
# of canisters 
( - ) 
(3) 
ARFxRF 
( - ) 
(4) 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
Mitigation 
Factor 
( - ) 
(5) 
Breathing 
Rate 
(mVsec) 
(6) 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
5000 meter X/Q 
(sec/m3) 
(7) 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
Dose due to 
Pu-waste 
(rem) 
(8) 
7.59E+00 
3.22E-04 
5.89E+01 
4.04E+01 
5.04E+02 
2.22E-04 
1.80E+01 
2.77E+01 
Dose due to 
HLW 
(rem) 
(9) 
1.41E-01 
1.37E-03 
1.90E+00 
8.05E-01 
9.54E+00 
1.37E-03 
3.53E-01 
5.78E-01 
Offsite 5000-m 
Can Dose 
(rem) 
(10) 
7.73E+00 
1.69E-03 
6.08E+01 
4.12E+01 
5.13E+02 
1.59E-03 
1.84E+01 
2.83E+01 
Off-Site Submersion Dose without HEPA Filters (10% HLW Displaced by Pu) 
Organ 
(1) 
Gonad 
Breast 
Lung 
R Marrow 
B Surface 
Thyroid 
Remainder 
Effective 
Skin 
Lens of Eye 
Pu-Dose 
(rem-m3/s-can) 
(2) 
2.32E+00 
2.92E+00 
1.81E+00 
1.40E+00 
7.70E+00 
2.11E+00 
1.70E+00 
2.21E+00 
3.61E+00 
0.00E+00 
# of canisters 
( - ) 
(3) 
ARF 
( - ) 
(4) 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
Mitigation 
Factor 
( - ) 
(5) 
5000 meter X/Q 
(sec/m3) 
(7) 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
Dose due to 
Pu-waste 
(rem) 
(8) 
1.45E-07 
1.82E-07 
1.13E-07 
8.76E-08 
4.80E-07 
1.32E-07 
1.06E-07 
1.38E-07 
2.25E-07 
0.00E+00 
Dose due to 
HLW 
(rem) 
(9) 
1.04E-05 
1.18E-05 
1.03E-05 
1.00E-05 
1.71E-05 
1.06E-05 
9.84E-06 
1.06E-05 
4.63E-05 
0.00E+00 
Offsite 5000-m 
Can Dose 
(rem) 
(10) 
1.05E-05 
1.20E-05 
1.04E-05 
1.01E-05 
1.75E-05 
1.07E-05 
9.95E-06 
1.07E-05 
4.65E-05 
O.OOE+OO 
CAL-WPS-SE-000001 REV 00 II-7 September 1999 
Fraction of HLW Displaced by Pu [1, p. 11] 
Continuation from Previous Page 
0.1 
Inhalation 
(8) = (2) x (3) x (4) x (5) x (6) x (7) x 0.1/0 12 
(9) = (1 - 0.1) x (3) x [HLW (11)] x (5)/[HLW (15)] x (6)/[HLW (13)] x (7)/[HLW (14)] 
(10) = (8)+ (9) 
Submersion 
(8) = (2) x (3) x (4) x (5) x (6) x (7) x 0 1/0.12 
(9) = (1 - 0 1) x (3) x [HLW (11)] x (5)/[HLW (15)] x (7)/[HLW (14)] 
(10) = (8)+ (9) 
no HEPAs 
Dose 
CEDE 
DDE (eff.) 
TEDE 
CDE (max) 
CDE + DDE 
Lens of Eye 
Skin 
5000-m 
(rem) 
28.298 
0.000 
28.298 
513.322 
513.322 
0.000 
4.649E-05 
CAL-WPS-SE-000001 REV 00 II-8 September 1999 
Off-Site Inhalation Dose with HEPA Filters (10% HLW Displaced by Pu) 
Organ 
(1) 
Gonad 
Breast 
Lung 
R Marrow 
B Surface 
Thyroid 
Remainder 
Effective 
Pu-Dose 
(rem/can) 
(2) 
3.65E+11 
1.55E+07 
2.83E+12 
1.94E+12 
2.42E+13 
1.07E+07 
8.67E+11 
1.33E+12 
#of 
canisters 
( - ) 
(3) 
ARFxRF 
( - ) 
(4) 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
Mitigation 
Factor 
( - ) 
(5) 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
Breathing 
Rate 
(m3/sec) 
(6) 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
5000 meter X/Q 
(sec/m) 
(7) 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
Dose due to 
Pu-waste 
(rem) 
(8) 
2.28E-03 
9.67E-08 
1.77E-02 
1.21E-02 
1.51E-01 
6.67E-08 
5.41E-03 
8.32E-03 
Dose due to 
HLW 
(rem) 
(9) 
4.24E-05 
4.10E-07 
5.70E-04 
2.41E-04 
2.86E-03 
4.10E-07 
1.06E-04 
1.73E-04 
Offsite 5000-m 
Can Dose 
(rem) 
(10) 
2.32E-03 
5.07E-07 
1.82E-02 
1.23E-02 
1.54E-01 
4.77E-07 
5.51E-03 
8.49E-03 
Off-Site Submersion Dose with HEPA Filters (10% HLW Displaced by Pu) 
Organ 
(1) 
Gonad 
Breast 
Lung 
R Marrow 
B Surface 
Thyroid 
Remainder 
Effective 
SWn 
Lens of Eye 
Pu-Dose 
(rem-m3/s-can) 
(2) 
2.32E+00 
2.92E+00 
1.81E+00 
1.40E+00 
7.70E+00 
2.11E+00 
1.70E+00 
2.21E+00 
3.61E+00 
0.00E+00 
#of 
canisters 
( - ) 
(3) 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
ARF 
( - ) 
(4) 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
Mitigation 
Factor 
( - ) 
(5) 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
5000 meter X/Q 
(sec/m) 
(7) 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
Dose due to 
Pu-waste 
(rem) 
(8) 
4.35E-11 
5.46E-11 
3.38E-11 
2.63E-11 
1.44E-10 
3.95E-11 
3.19E-11 
4.13E-11 
6.75E-11 
0.00E+00 
Dose due to 
HLW 
(rem) 
(9) 
3.11E-09 
3.55E-09 
3.08E-09 
3.01E-09 
5.12E-09 
3.17E-09 
2.95E-09 
3.17E-09 
1.39E-08 
0.00E+00 
Offsite 5000-m 
Can Dose 
(rem) 
(10) 
3.15E-09 
3.60E-09 
3.12E-09 
3.03E-09 
5.26E-09 
3.21E-09 
2.99E-09 
3.22E-09 
1.39E-08 
O.OOE+00 
CAL-WPS-SE-000001 REV 00 II-9 September 1999 
Fraction of HLW Displaced by Pu [1, p. 11] = 
Inhalation 
(8) = (2) x (3) x (4) x (5) x (6) x (7) x 0.1/0.12 
(9) = (1 - 0.1) x (3) x [HLW (11)] x (5)/[HLW (15)] x (6)/[HLW (13)] x 
(10)-(8)+ (9) 
Submersion 
(8) = (2) x (3) x (4) x (5) x (6) x (7) x 0.1/0.12 
(9) = (1 - 0.1) x (3) x [HLW (11)] x (5)/[HLW (15)] x (7)/[HLW (14)] 
(10) = (8)+ (9) 
Continuation from Previous Page 
HEPAs 
Dose 
CEDE 
DDE (eff.) 
TEDE 
CDE (max) 
CDE + DDE 
Lens of Eye 
Skin 
5000-m 
(rem) 
0.008 
0.000 
0.008 
0.154 
0.154 
0.000 
0.000 
CAL-WPS-SE-000001 REV 00 11-10 September 1999 
Off-Site Inhalation Dose without HEPA Filters (12% HLW Displaced by Pu) 
Organ 
(1) 
Gonad 
Breast 
Lung 
R Marrow 
B Surface 
Thyroid 
Remainder 
Effective 
Pu-Dose 
(rem/can) 
(2) 
3.65E+11 
1.55E+07 
2.83E+12 
1.94E+12 
2.42E+13 
1.07E+07 
8.67E+11 
1.33E+12 
#of 
canisters 
( - ) 
(3) 
ARFxRF 
( - ) 
(4) 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
Mitigation 
Factor 
( - ) 
(5) 
Breathing 
Rate 
(m3/sec) 
(6) 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
5000 meter X/Q 
(sec/m3) 
(7) 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
Dose due to 
Pu-waste 
(rem) 
(8) 
9.11E+00 
3.87E-04 
7.07E+01 
4.84E+01 
6.05E+02 
2.67E-04 
2.16E+01 
3.33E+01 
Dose due to 
HLW 
(rem) 
(9) 
1.38E-01 
1.34E-03 
1.86E+00 
7.87E-01 
9.33E+00 
1.34E-03 
3.45E-01 
5.65E-01 
Offsite 5000-m 
Can Dose 
(rem) 
(10) 
9.25E+00 
1.72E-03 
7.25E+01 
4.92E+01 
6.14E+02 
1.60E-03 
2.20E+01 
3.38E+01 
Off-Site Submersion Dose without HEPA Filters (12% HLW Displaced by Pu) 
Organ 
(1) 
Gonad 
Breast 
Lung 
R Marrow 
B Surface 
Thyroid 
Remainder 
Effective 
Skin 
Lens of Eye 
Pu-Dose 
(rem-m3/s-can) 
(2) 
2.32E+00 
2.92E+00 
1.81E+00 
1.40E+00 
7.70E+00 
2.11E+00 
1.70E+00 
2.21E+00 
3.61E+00 
O.OOE+00 
#of 
canisters 
( - ) 
(3) 
ARF 
( - ) 
(4) 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
Mitigation 
Factor 
( - ) 
(5) 
5000 meter X/Q 
(sec/m3) 
(7) 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
Dose due to 
Pu-waste 
(rem) 
(8) 
1.74E-07 
2.18E-07 
1.35E-07 
1.05E-07 
5.76E-07 
1.58E-07 
1.28E-07 
1.65E-07 
2.70E-07 
0.00E+00 
Dose due to 
HLW 
(rem) 
(9) 
1.01E-05 
1.16E-05 
1.01E-05 
9.80E-06 
1.67E-05 
1.03E-05 
9.63E-06 
1.03E-05 
4.52E-05 
0.00E+00 
Offsite 5000-m 
Can Dose 
(rem) 
(10) 
1.03E-05 
1.18E-05 
1.02E-05 
9.91E-06 
1.72E-05 
1.05E-05 
9.75E-06 
1.05E-05 
4.55E-05 
0.00E+00 
CAL-WPS-SE-000001 REV 00 11-11 September 1999 
Fraction of HLW Displaced by Pu [1, p. 11] 
Continuation from Previous Page 
0.12 
Inhalation 
(8) = (2) x (3) x (4) x (5) x (6) x (7) x 0.12/0.12 
(9) = (1 - 0.12) x (3) x [HLW (11)] x (5)/[HLW (15)] x (6)/[HLW (13)] x (7)/[HLW (14)] 
(10) = (8)+ (9) 
Submersion 
(8) = (2) x (3) x (4) x (5) x (6) x (7) x 0.12/0 12 
(9) = (1 - 0.12) x (3) x [HLW (11)] x (5)/[HLW (15)] x (7)/[HLW (14)] 
(10) = (8)+ (9) 
no HEPAs 
Dose 
CEDE 
DDE (eff.) 
TEDE 
CDE (max) 
CDE+DDE 
Lens of Eye 
Skin 
5000-m 
(rem) 
33.829 
0.000 
33.829 
613.866 
613.866 
0.000 
4.550E-05 
CAL-WPS-S E-000001 REV 00 11-12 September 1999 
Off-Site Inhalation Dose with HEPA Filters (12% HLW Displaced by Pu) 
Organ 
(1) 
Gonad 
Breast 
Lung 
R Marrow 
B Surface 
Thyroid 
Remainder 
Effective 
Pu-Dose 
(rem/can) 
(2) 
3.65E+11 
1.55E+07 
2.83E+12 
1.94E+12 
2.42E+13 
1.07E+07 
8.67E+11 
1.33E+12 
#of 
canisters 
( - ) 
(3) 
ARFxRF 
( - ) 
(4) 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
Mitigation 
Factor 
( - ) 
(5) 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
Breathing 
Rate 
(m3/sec) 
(6) 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
5000 meter X/Q 
(sec/m3) 
(7) 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
Dose due to 
Pu-waste 
(rem) 
(8) 
2.73E-03 
1.16E-07 
2.12E-02 
1.45E-02 
1.81E-01 
8.00E-08 
6.49E-03 
9.98E-03 
Dose due to 
HLW 
(rem) 
(9) 
4.14E-05 
4.01E-07 
5.57E-04 
2.36E-04 
2.80E-03 
4.01E-07 
1.03E-04 
1.69E-04 
Offsite 5000-m 
Can Dose 
(rem) 
(10) 
2.78E-03 
5.17E-07 
2.18E-02 
1.48E-02 
1.84E-01 
4.81E-07 
6.59E-03 
1.01E-02 
Off-Site Submersion Dose with HEPA Filters (12% HLW Displaced by Pu) 
Organ 
(1) 
Gonad 
Breast 
Lung 
R Marrow 
B Surface 
Thyroid 
Remainder 
Effective 
Skin 
Lens of Eye 
Pu-Dose 
(rem-m3/s-can) 
(2) 
2.32E+00 
2.92E+00 
1.81E+00 
1.40E+00 
7.70E+00 
2.11E+00 
1.70E+00 
2.21E+00 
3.61E+00 
0.00E+00 
#of 
canisters 
( - ) 
(3) 
ARF 
( - ) 
(4) 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
Mitigation 
Factor 
( - ) 
(5) 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
5000 meter X/Q 
(sec/m3) 
(7) 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
Dose due to 
Pu-waste 
(rem) 
(8) 
5.22E-11 
6.55E-11 
4.06E-11 
3.15E-11 
1.73E-10 
4.74E-11 
3.83E-11 
4.96E-11 
8.10E-11 
0.00E+00 
Dose due to 
HLW 
(rem) 
(9) 
3.04E-09 
3.47E-09 
3.02E-09 
2.94E-09 
5.00E-09 
3.10E-09 
2.89E-09 
3.10E-09 
1.36E-08 
0.00E+00 
Offsite 5000-m 
Can Dose 
(rem) 
(10) 
3.09E-09 
3.54E-09 
3.06E-09 
2.97E-09 
5.17E-09 
3.15E-09 
2.93E-09 
3.15E-09 
1.37E-08 
0.00E+00 
CAL-WPS-SE-000001 REV 00 11-13 September 1999 
Fraction of HLW Displaced by Pu [1, p. 11] = 
Inhalation 
(8) = (2) x (3) x (4) x (5) x (6) x (7) x 0.12/0.12 
(9) = (1 - 0.12) x (3) x [HLW (11)] x (5)/[HLW (15)] x (6)/[HLW (13)] x 
(10) = (8)+ (9) 
Submersion 
(8) = (2) x (3) x (4) x (5) x (6) x (7) x 0.12/0.12 
(9) = (1 - 0.12) x (3) x [HLW (11)] x (5)/[HLW (15)] x (7)/[HLW (14)] 
(10) = (8)+ (9) 
Continuation from Previous Page 
HEPAs 
Dose 
CEDE 
DDE (eff.) 
TEDE 
CDE (max) 
CDE + DDE 
Lens of Eye 
Skin 
5000-m 
(rem) 
0.010 
0.000 
0.010 
0.184 
0.184 
0.000 
0.000 
CAL-WPS-SE-000001 REV 00 11-14 September 1999 
Off-Site Inhalation Dose without HEPA Filters (20% HLW Displaced by Pu) 
Organ 
(1) 
Gonad 
Breast 
Lung 
R Marrow 
B Surface 
Thyroid 
Remainder 
Effective 
Pu-Dose 
(rem/can) 
(2) 
3.65E+11 
1.55E+07 
2.83E+12 
1.94E+12 
2.42E+13 
1.07E+07 
8.67E+11 
1.33E+12 
#of 
canisters 
( - ) 
(3) 
ARFxRF 
( - ) 
(4) 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
Mitigation 
Factor 
( - ) 
(5) 
Breathing 
Rate 
(m3/sec) 
(6) 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
5000 meter X/Q 
(sec/m3) 
(7) 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
Dose due to 
Pu-waste 
(rem) 
(8) 
1.52E+01 
6.45E-04 
1.18E+02 
8.07E+01 
1.01E+03 
4.45E-04 
3.60E+01 
5.54E+01 
Dose due to 
HLW 
(rem) 
(9) 
1.26E-01 
1.22E-03 
1.69E+00 
7.15E-01 
8.48E+00 
1.22E-03 
3.14E-01 
5.14E-01 
Offsite 5000-m 
Can Dose 
(rem) 
(10) 
1.53E+01 
1.86E-03 
1.20E+02 
8.14E+01 
1.02E+03 
1.66E-03 
3.64E+01 
5.60E+01 
Off-Site Submersion Dose without HEPA Filters (20% HLW Displaced by Pu) 
Organ 
(1) 
Gonad 
Breast 
Lung 
R Marrow 
B Surface 
Thyroid 
Remainder 
Effective 
Skin 
Lens of Eye 
Pu-Dose 
(rem-m3/s-can) 
(2) 
2.32E+00 
2.92E+00 
1.81E+00 
1.40E+00 
7.70E+00 
2.11E+00 
1.70E+00 
2.21E+00 
3.61E+00 
0.00E+00 
#of 
canisters 
( - ) 
(3) 
ARF 
( - ) 
(4) 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
Mitigation 
Factor 
( - ) 
(S) 
5000 meter X/Q 
(sec/m ) 
(7) 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
Dose due to 
Pu-waste 
(rem) 
(8) 
2.90E-07 
3.64E-07 
2.26E-07 
1.75E-07 
9.61E-07 
2.64E-07 
2.13E-07 
2.76E-07 
4.50E-07 
0.00E+00 j 
Dose due to 
HLW 
(rem) 
(9) 
9.21E-06 
1.05E-05 
9.14E-06 
8.91E-06 
1.52E-05 
9.40E-06 
8.75E-06 
9.40E-06 
4.11E-05 
| _ 0.00E+00 
Offsite 5000-m 
Can Dose 
(rem) 
(10) 
9.50E-06 
1.09E-05 
9.37E-06 
9.08E-06 
1.61E-05 
9.67E-06 
8.96E-06 
9.68E-06 
4.16E-05 
0.00E+00 
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Fraction of HLW Displaced by Pu [1, p. 11] = 
Continuation from Previous Page 
0.2 
Inhalation 
(8) = (2) x (3) x (4) x (5) x (6) x (7) x 0.2/0.12 
(9) = (1 - 0,2) x (3) x [HLW (11)] x (5)/[HLW (15)] x (6)/[HLW (13)] x (7)/[HLW (14)] 
(10) = (8)+ (9) 
Submersion 
(8) = (2) x (3) x (4) x (5) x (6) x (7) x 0.2/0.12 
(9) = (1 - 0.2) x (3) x [HLW (11)] x (5)/[HLW (15)] x (7)/[HLW (14)] 
(10) = (8)+ (9) 
no HEPAs 
Dose 
CEDE 
DDE (eff.) 
TEDE 
CDE (max) 
CDE+DDE 
Lens of Eye 
Skin 
5000-m 
(rem) 
55.954 
0.000 
55.954 
1016.043 
1016.043 
0.000 
4.157E-05 
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Off-Site Inhalation Dose with HEPA Filters (20% HLW Displaced by Pu) 
Organ 
(1) 
Gonad 
Breast 
Lung 
R Marrow 
B Surface 
Thyroid 
Remainder 
Effective 
Pu-Dose 
(rem/can) 
(2) 
3.65E+11 
1.55E+07 
2.83E+12 
1.94E+12 
2.42E+13 
1.07E+07 
8.67E+11 
1.33E+12 
#of 
canisters 
( - ) 
(3) 
ARFxRF 
( - ) 
(4) 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
Mitigation 
Factor 
( - ) 
(5) 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
Breathing 
Rate 
(m3/sec) 
(6) 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
3.33E-04 
5000 meter X/Q 
(sec/m3) 
(7) 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
Dose due to 
Pu-waste 
(rem) 
(8) 
4.56E-03 
1.93E-07 
3.53E-02 
2.42E-02 
3.02E-01 
1.33E-07 
1.08E-02 
1.66E-02 
Dose due to 
HLW 
(rem) 
(9) 
3.77E-05 
3.65E-07 
5.06E-04 
2.15E-04 
2.54E-03 
3.65E-07 
9.41E-05 
1.54E-04 
Offsite 5000-m 
Can Dose 
(rem) 
(10) 
4.59E-03 
5.58E-07 
3.59E-02 
2.44E-02 
3.05E-01 
4.98E-07 
1.09E-02 
1.68E-02 
Off-Site Submersion Dose with HEPA Filters (20% HLW Displaced by Pu) 
Organ 
(1) 
Gonad 
Breast 
Lung 
R Marrow 
B Surface 
Thyroid 
Remainder 
Effective 
Skin 
Lens of Eye 
Pu-Dose 
(rem-m /s-can) 
(2) 
2.32E+00 
2.92E+00 
1.81E+00 
1.40E+00 
7.70E+00 
2.11E+00 
1.70E+00 
2.21E+00 
3.61E+00 
0.00E+00 
#of 
canisters 
( - ) 
(3) 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
ARF 
( - ) 
(4) 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
1.60E-03 
Mitigation 
Factor 
( - ) 
(5) 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
3.00E-04 
5000 meter X/Q 
(sec/m3) 
(7) 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
4.68E-05 
Dose due to 
Pu-waste 
(rem) 
(8) 
8.69E-11 
1.09E-10 
6.77E-11 
5.25E-11 
2.88E-10 
7.91E-11 
6.38E-11 
8.27E-11 
1.35E-10 
0.00E+00 
Dose due to 
HLW 
(rem) 
(9) 
2.76E-09 
3.15E-09 
2.74E-09 
2.67E-09 
4.55E-09 
2.82E-09 
2.63E-09 
2.82E-09 
1.23E-08 
0.00E+00 
Offsite 5000-m 
Can Dose 
(rem) 
(10) 
2.85E-09 
3.26E-09 
2.81E-09 
2.73E-09 
4.84E-09 
2.90E-09 
2.69E-09 
2.90E-09 
1.25E-08 
0.00E+00 
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Fraction of HLW Displaced by Pu [1, p. 11] = 
Inhalation 
(8) = (2) x (3) x (4) x (5) x (6) x (7) x 0.2/0.12 
(9) = (1 - 0.2) x (3) x [HLW (11)] x (5)/[HLW (15)] x (6)/[HLW (13)] x 
(10) = (8)+ (9) 
Submersion 
(8) = (2) x (3) x (4) x (5) x (6) x (7) x 0.2/0.12 
(9) = (1 - 0.2) x (3) x [HLW (11)] x (5)/[HLW (15)] x (7)/[HLW (14)] 
(10) = (8)+ (9) 
Continuation from Previous Page 
HEPAs 
Dose 
CEDE 
DDE (eff.) 
TEDE 
CDE (max) 
CDE+DDE 
Lens of Eye 
Skin 
5000-m 
(rem) 
0.017 
0.000 
0.017 
0.305 
0.305 
0.000 
0.000 
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Attachment III 
Pu Can-In-Canister Sketch 
Latch Support 
Plats 
Glass Fill 
Line 
Tie Rod 
(Typical) 
Expanded or 
Perforated Metal 
Magazine Sleeve 
Cans 
Scalloped 
Plate 
Magazines 
Latch 
(Typical) 
Scalloped 
Plate 
Magazines 
Cans 
SECTION A-A 
Separate Spacers 
Or Handling Lugs 
Magazine 
Socket 
Plate 
SECTION B-B 
Magazines 
Cans 
SECTION c-e 
Tie Rod 
(Typical) 
Tie Rod 
(Typical) 
Tie Rod 
(Typical) 
Can-In-Canister sketch from SRS showing cross section with 4 cans in a tube and 
7 tubes in a DWPF canister (CRWMS M&O 1998, Figure 2.2-1) 
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Guide 
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Preliminary X/Q Concentration Estimates 
Using NRC Regulatory Guide 1.145 as 
Implemented by the XQI45 Software 
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TBV-
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7. TBV/TBD 
Priority 
2 
2 
2 
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8. TBV Due To 
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N/A 
N/A 
X 
N/A 
From 
Uncontrolled 
Source 
X 
X 
X 
X 
Un-
confirmer 
N/A 
N/A 
N/A 
N/A 
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p. 7-7 
Table 
III.l 
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Attachment V 
Calculations for Figures 6-1 and 6-2 
The following pages contain a listing of the Excel 97 spreadsheets used to calculate the data used 
in Figures 6-1 and 6-2 in the text. The following is a listing of the spreadsheets involved: 
• Figure 6.1 - calculations to plot Figure 6-1. This Figure illustrates the effect of 
changing the fraction of HLW displaced by Pu. 
• Figure 6.2 - calculations to plot Figure 6-2. This Figure illustrates the effect of 
changing the ARF on canister doses. 
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X 
0.000 
0.050 
0.100 
0.150 
0.200 
0.250 
0.300 
0.350 
0.400 
0.450 
0.500 
0.550 
0.600 
0.650 
0.700 
0.750 
0.800 
0.850 
0.900 
0.950 
1.000 
ratio x/0.12 
0.000 
0.417 
0.833 
1.250 
1.667 
2.083 
2.500 
2.917 
3.333 
3.750 
4.167 
4.583 
5.000 
5.417 
5.833 
6.250 
6.667 
7.083 
7.500 
7.917 
8.333 
Dose (rem) 
Pu TEDE 
0.000 
13.860 
27.720 
41.580 
55.441 
69.301 
83.161 
97.021 
110.881 
124.741 
138.601 
152.462 
166.322 
180.182 
194.042 
207.902 
221.762 
235.623 
249.483 
263.343 
277.203 
HLW TEDE 
0.642 
0.610 
0.578 
0.546 
0.514 
0.482 
0.449 
0.417 
0.385 
0.353 
0.321 
0.289 
0.257 
0.225 
0.193 
0.161 
0.128 
0.096 
0.064 
0.032 
0.000 
TEDE 
0.642 
14.470 
28.298 
42.126 
55.954 
69.782 
83.610 
97.438 
111.266 
125.094 
138.922 
152.751 
166.579 
180.407 
194.235 
208.063 
221.891 
235.719 
249.547 
263.375 
277.203 
Pu (CDE+DDE) 
0.000 
251.891 
503.782 
755.673 
1007.563 
1259.454 
1511.345 
1763.236 
2015.127 
2267.018 
2518.908 
2770.799 
3022.690 
3274.581 
3526.472 
3778.363 
4030.253 
4282.144 
4534.035 
4785.926 
5037.817 
HLW (CDE+DDE) 
10.600 
10.070 
9.540 
9.010 
8.480 
7.950 
7.420 
6.890 
6.360 
5.830 
5.300 
4.770 
4.240 
3.710 
3.180 
2.650 
2.120 
1.590 
1.060 
0.530 
0.000 
CDE + DDE 
10.600 
261.961 
513.322 
764.683 
1016.043 
1267.404 
1518.765 
1770.126 
2021.487 
2272.848 
2524.208 
2775.569 
3026.930 
3278.291 
3529.652 
3781.013 
4032.373 
4283.734 
4535.095 
4786.456 
5037.817 
CAL-WPS-SE-000001, REV 00 V-2 September 1999 
1.0E+04 
1.0E+03 
1.0E+02 
E 
O (0 O 
Q 1 OE+01 11 
1 OE+00 
1.0E-01 
1.0E+04 
1.0E+03 
1 OE+02 
1.OE+01 
1.OE+00 
1.0E-01 
0.00 010 0.20 0.30 0.40 0.50 0.60 0.70 0.80 
% of HLW Displaced by Pu 
0.90 1.00 
■Maximum Organ (CDE+DDE) -©-TEDE 
CAL-WPS-SE-000001, REV 00 V-3 September 1999 
ARF 
1.00E-06 
1.60E-06 
2.56E-06 
4.10E-06 
6.55E-06 
1.05E-05 
1.68E-05 
2.68E-05 
4.29E-05 
6.87E-05 
1.10E-04 
1.76E-04 
2.81 E-04 
4.50E-04 
7.21 E-04 
1.15E-03 
1.84E-03 
2.95E-03 
4.72E-03 
7.56E-03 
1.00E-02 
ratio 
ARF/0.0016 
6.25E-04 
1.00E-03 
1.60E-03 
2.56E-03 
4.10E-03 
6.55E-03 
1.05E-02 
1.68E-02 
2.68E-02 
4.29E-02 
6.87E-02 
1.10E-01 
1.76E-01 
2.81E-01 
4.50E-01 
7.21 E-01 
1.15E+00 
1.84E+00 
2.95E+00 
4.72E+00 
6.25E+00 
Dose (rem) 
Pu TEDE 
0.021 
0.033 
0.053 
0.085 
0.136 
0.218 
0.349 
0.558 
0.893 
1.429 
2.286 
3.657 
5.852 
9.363 
14.981 
23.969 
38.351 
61.362 
98.179 
157.086 
207.902 
HLW TEDE 
0.565 
0.565 
0.565 
0.565 
0.565 
0.565 
0.565 
0.565 
0.565 
0.565 
0.565 
0.565 
0.565 
0.565 
0.565 
0.565 
0.565 
0.565 
0.565 
0.565 
0.565 
TEDE 
0.586 
0.598 
0.618 
0.650 
0.701 
0.783 
0.914 
1.123 
1.458 
1.994 
2.851 
4.222 
6.417 
9.928 
15.546 
24.534 
38.916 
61.927 
98.744 
157.651 
208.467 
Pu (CDE+DDE) 
0.378 
0.605 
0.967 
1.548 
2.476 
3.962 
6.339 
10.142 
16.228 
25.965 
41.544 
66.470 
106.351 
170.162 
272.260 
435.616 
696.985 
1115.176 
1784.281 
2854.850 
3778.363 
HLW (CDE+DDE) 
9.328 
9.328 
9.328 
9.328 
9.328 
9.328 
9.328 
9.328 
9.328 
9.328 
9.328 
9.328 
9.328 
9.328 
9.328 
9.328 
9.328 
9.328 
9.328 
9.328 
9.328 
CDE + DDE 
9.706 
9.933 
10.295 
10.876 
11.804 
13.290 
15.667 
19.470 
25.556 
35.293 
50.872 
75.798 
115.679 
179.490 
281.588 
444.944 
706.313 
1124.504 
1793.609 
2864.178 
3787.691 
CAL-WPS-SE-000001, REV 00 September 1999 
1.0E+03 
1.0E+02 
1.OE+01 
E 
d> 
<u </> o Q 
1,OE+00 
1 .OE-01 
1 .OE-02 
1.0E-06 1.0E-05 1.0E-04 1.0E-03 
Airborne Release Fraction 
1.0E+04 
1.0E+03 
1 .OE+02 
1.OE+01 
1.OE+00 
: 1.0E-01 
1.0E-02 
1.OE-02 
■Pu TEDE -©-TEDE Can - A - P u (CDE+DDE) -X-CDE+DDE Can 
CAL-WPS-SE-000001, REV 00 V-5 September 1999 
